Microbot Medical Inc. announced Emory University Hospital as the first to adopt the LIBERTY Endovascular Robotic System.
LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
Emory University Hospital's adoption of LIBERTY aligns with its commitment to the field of interventional radiology.
Emory University Hospital Adoption
Emory University Hospital is the first to adopt the LIBERTY Endovascular Robotic System for patient care.
LIBERTY Unique Features
LIBERTY is designed for precise vascular navigation to reduce radiation exposure and physical strain.
Market Release Plan
Microbot plans a full market release of LIBERTY at the SIR conference in April 2026 to deepen market adoption.
Clinical Applications
LIBERTY supports precise care for procedures including liver tumor embolization and uterine fibroid embolization.
Strategic Collaboration
Microbot is collaborating with Emory to enhance the specialty field of interventional radiology.
- The collaboration with Emory University Hospital signifies a significant milestone for Microbot Medical in the surgical robotic space.
- The adoption of LIBERTY showcases Microbot's dedication to innovation and advancing medical robotics.
The adoption of the LIBERTY Endovascular Robotic System by Emory University Hospital marks a groundbreaking achievement in robotic medical technology, paving the way for future advancements in endovascular care.